This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Educational Activity

How to Evaluate Patients for Tardive Dyskinesia

Andrew A. Nierenberg, MD

Published: December 1, 2020

This CME activity is expired. For more CME activities, visit
Find more articles on this and other psychiatry and CNS topics:
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders

Tardive dyskinesia (TD) is a serious and potentially irreversible movement disorder that occurs in 20%–50% of patients taking antipsychotic drugs. TD is also associated with several other classes of medications, including antidepressants, antihistamines, decongestants, mood stabilizers, and stimulants. As more people are prescribed medications that can increase the risk for TD, it is important that clinicians learn how to systematically and reasonably evaluate their patients for this potentially dangerous and debilitating condition.

To cite: Nierenberg AA. How to evaluate patients for tardive dyskinesia. J Clin Psychiatry. 2021;82(1):NU19047BR1C.
To share:

© Copyright 2020 Physicians Postgraduate Press, Inc.

From the Bipolar Clinic and Research Program and the Depression Clinic and Research Program, Massachusetts General Hospital; and Department of Psychiatry, Harvard Medical School, Boston.

Volume: 82

Quick Links: